Nitric oxide produces HLA-G nitration and induces metalloprotease-dependent shedding creating a tolerogenic milieu.
about
Some basic aspects of HLA-G biologyThe dual role of HLA-G in cancerHLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism.Immunological deregulation in classic hodgkin lymphoma.Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?HLA-G: a human pregnancy-related immunomodulator.Wharton's jelly mesenchymal stem cells as candidates for beta cells regeneration: extending the differentiative and immunomodulatory benefits of adult mesenchymal stem cells for the treatment of type 1 diabetes.HLA-G regulators in cancer medicine: an outline of key requirements.The immunosuppressive molecule HLA-G and its clinical implications.Oxidative stress associated to dysfunctional adipose tissue: a potential link between obesity, type 2 diabetes mellitus and breast cancer.Soluble monomers, dimers and HLA-G-expressing extracellular vesicles: the three dimensions of structural complexity to use HLA-G as a clinical biomarker.Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding.Clinical correlates of human leucocyte antigen (HLA)-G in systemic sclerosis.In vivo identification of an HLA-G complex as ubiquitinated protein circulating in exosomes.
P2860
Q26852671-844949D2-7AFE-4203-A374-D4439922A265Q26860886-ACB5D35C-84F6-4750-844E-FAEACA71796CQ33558697-F33D098C-C9B5-44F7-AB32-89C0E5F8643DQ33778391-0F66F6D4-7E0E-481B-83C8-D066E5F2D64FQ36184793-3B6D0F14-E2AE-420F-8FE8-4DC1B9D6E330Q37355186-08D71368-4F37-4ED3-9C1E-266E2A4553B7Q37802776-F7D8A89A-8D88-49BD-9FB6-AA243F879BA2Q37906387-DCFF9EC7-F993-4CD2-947B-94C96A57A573Q38005743-CF705D29-723D-41BE-A508-2A67800BDB01Q38081505-880F56AB-A039-4858-9520-41DE6BB6E7FDQ38839474-290D6E26-3E7B-4E66-BDD4-459E07F36466Q39143880-6EDD6D2F-C612-436A-A089-03125A67D3E7Q41108942-0FEB69A4-C60B-4948-B182-E5B31A65FEA9Q51066607-647E3D3D-23B5-4743-9531-5C893612BC7F
P2860
Nitric oxide produces HLA-G nitration and induces metalloprotease-dependent shedding creating a tolerogenic milieu.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Nitric oxide produces HLA-G ni ...... creating a tolerogenic milieu.
@en
Nitric oxide produces HLA-G ni ...... creating a tolerogenic milieu.
@nl
type
label
Nitric oxide produces HLA-G ni ...... creating a tolerogenic milieu.
@en
Nitric oxide produces HLA-G ni ...... creating a tolerogenic milieu.
@nl
prefLabel
Nitric oxide produces HLA-G ni ...... creating a tolerogenic milieu.
@en
Nitric oxide produces HLA-G ni ...... creating a tolerogenic milieu.
@nl
P2093
P2860
P1433
P1476
Nitric oxide produces HLA-G ni ...... creating a tolerogenic milieu.
@en
P2093
Alvaro González
Angel Díaz-Lagares
Edgardo D Carosella
Estibaliz Alegre
Joel LeMaoult
P2860
P304
P356
10.1111/J.1365-2567.2008.02911.X
P577
2008-09-01T00:00:00Z